CEO Pascal Soriot’s share purchase suggests that AstraZeneca still doesn’t have the Phase III AVANZAR results for Datroway – which could be good news for the blockbuster bet.
CEO Pascal Soriot’s share purchase suggests that AstraZeneca still doesn’t have the Phase III AVANZAR results for Datroway – which could be good news for the blockbuster bet.